Position and assignments
In the face of rising antibiotic resistance, targeting bacterial virulence factors offers a promising alternative to traditional antimicrobial therapies. Unlike conventional antibiotics that kill or inhibit bacterial growth—thus exerting strong selective pressure for resistance—anti-virulence strategies aim to disarm pathogens by neutralizing their ability to cause disease. Because these approaches do not directly affect bacterial viability, they impose less evolutionary pressure , potentially limiting the emergence of resistance and preserving the effectiveness of existing antibiotics. Targeting virulence factors thus represents a novel and sustainable path in the fight against drug-resistant bacterial infections. This project focuses on the development of nanomedicine candidates designed to neutralize key virulence factors from two WHO-designated high-priority pathogens. By disrupting bacterial pathogenesis rather than viability, these candidates offer a novel and sustainable approach to treating drug-resistant infections. This project is highly interdisciplinary integrating expertise in molecular biology, protein engineering, and computational antibody design to develop novel biologics with therapeutic potential. It will be carried out in close collaboration with clinicians who provide access to relevant biological samples, ensuring a strong translational dimension.
Key Responsibilities
Geographic mobility :
National
Telework
Occasionnal
Starting date
Profile
Research Position In • Liège, Belgium